• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Paysign Inc.

    8/7/24 6:05:10 PM ET
    $PAYS
    EDP Services
    Technology
    Get the next $PAYS alert in real time by email
    S-8 1 paysign_s8.htm FORM S-8

    As filed with the Securities and Exchange Commission on August 7, 2024

    Registration No. 333-

     

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

     

    FORM S-8

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

     

    PAYSIGN, INC.
    (Exact name of registrant as specified in its charter)

     

    Nevada

     

    95-4550154

    (State or other jurisdiction of
    incorporation or organization)
      (I.R.S. Employer
    Identification No.)

     

    2615 St. Rose Parkway
    Henderson, Nevada 89052

    (Address of Principal Executive Offices) (Zip Code)

     

     

    PAYSIGN, INC.

    2023 EQUITY INCENTIVE PLAN

    (Full Title of the Plan)

     

    Mark R. Newcomer

    Chief Executive Officer

    Paysign, Inc.

    2615 St. Rose Parkway
    Henderson, Nevada 89052
    (Name and Address of Agent for Service)

     

    (702) 453-2221

    (Telephone Number, Including Area Code, of Agent for Service)

     

     

    Copy to:

    Brian H. Blaney, Esq.

    Greenberg Traurig, LLP
    2375 E. Camelback Road, Suite 800

    Phoenix, Arizona 85016

    (602) 445-8000

     

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ☐   Non-accelerated filer ☒   Smaller reporting company ☒
    Accelerated filer ☐       Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     

     

       

     

     

    PART I
    INFORMATION REQUIRED IN THE
    SECTION 10(a) PROSPECTUS

     

    Items 1 and 2, and the documents incorporated by reference in this Registration Statement pursuant to Item 3 of Part II of this prospectus, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act of 1933, as amended (the “Securities Act”).

     

    Item 1. Plan Information.

     

    The documents containing the information specified in this Item 1 will be sent or given to participants of Paysign’s 2023 Equity Incentive Plan (the “Plan”) as specified by Rule 428(b)(1) under the Securities Act. In accordance with the rules and regulations of the Securities and Exchange Commission (the “Commission”) and the instructions to Form S-8, such documents are not being filed with the Commission either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act.

     

    Item 2. Registrant Information and Employee Plan Annual Information.

     

    The documents containing the information specified in this Item 2 and incorporated by reference in Item 3 of Part II of this Registration Statement will be sent or given to participants of the Plan, without charge, upon written or oral request, as specified by Rule 428(b)(1) under the Securities Act. The request shall be directed to our Corporate Secretary, Robert Strobo, Esq., at 2615 St. Rose Parkway, Henderson, Nevada 89052 or by telephone at (702) 453-2221. In accordance with the rules and regulations of the Commission and the instructions to Form S-8, such documents are not being filed with the Commission either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act.

     

     

     

     

     

     

     

     

     2 

     

     

    PART II
    INFORMATION REQUIRED IN THE
    REGISTRATION STATEMENT

     

    Item 3. Incorporation of Documents by Reference.

     

    The following documents, which we have filed with the Commission, are incorporated by reference in this Registration Statement:

     

    (a)Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Commission on March 27, 2024;
    (b)Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, as filed with the Commission on May 8, 2024;
    (c)Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, as filed with the Commission on August 1, 2024;
    (d)Definitive Proxy Statement on Schedule 14A, as filed with the Commission on March 29, 2024;
    (e)Current Reports on Form 8-K as filed with the Commission on January 29, 2024, March 15, 2024, April 19, 2024, May 7, 2024, and July 31, 2024, but only to the extent that the items therein are specifically stated to be “filed” rather than “furnished” for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”); and
    (f)The description of our Common Stock contained in Exhibit 4.2 to the Annual Report on Form 10-K for the year ended December 31, 2019, as filed with the Commission on April 3, 2020, including any amendment or report filed for the purpose of updating such description.

     

    In addition, all documents subsequently filed with the Commission by us pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents; except as to any portion of any future annual or quarterly report to stockholders or document or current report furnished under Item 2.02 or 7.01 of Form 8-K that is not deemed “filed” under such provisions. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement. Under no circumstances will any information furnished under Item 2.02 or 7.01 of Form 8-K be deemed incorporated herein by reference unless such Form 8-K expressly provides to the contrary.

     

    You should rely only on the information provided or incorporated by reference in this Registration Statement or any related prospectus. We have not authorized anyone to provide you with different information. You should not assume that the information in this Registration Statement or any related prospectus is accurate as of any date other than the date on the front of the document.

     

    Item 4. Description of Securities.

     

    Not applicable.

     

    Item 5. Interests of Named Experts and Counsel.

     

    Not applicable.

     

     

     

     

     3 

     

     

    Item 6. Indemnification of Directors and Officers.

     

    We are a Nevada corporation. Section 78.7502 of Chapter 78 of the Nevada Revised Statutes (“NRS”) empowers a corporation to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, except an action by or in the right of the corporation, by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise or as a manager of a limited-liability company, against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with the action, suit or proceeding if the person (a) is not liable pursuant to NRS Section 78.138; or (b) acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the conduct was unlawful. Under NRS Section 78.138, a director or officer is not individually liable to the corporation unless such person breached their fiduciary duty and such breach involved intentional misconduct, fraud or a knowing violation of law. If the action or suit is by or in the right of the corporation, indemnification may not be made for any claim, issue or matter as to which such a person has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals therefrom, to be liable to the corporation or for amounts paid in settlement to the corporation, unless and only to the extent that the court in which the action or suit was brought or other court of competent jurisdiction determines upon application that in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper.

     

    Under Article V.B of our Amended and Restated Articles of Incorporation, we are required to indemnify, to the fullest extent permitted by Nevada law, its officers and directors. Furthermore, Article V.C of our Amended and Restated Articles of Incorporation, we are required to pay (or through insurance purchased and maintained by us or through other financial arrangements) any expenses of an officer or director as they are incurred and in advance of the final disposition of a civil or criminal action, suit or proceeding, upon receipt of an undertaking by or on behalf of the director or officer to repay the amount if it is ultimately determined by a court of competent jurisdiction that he or she is not entitled to be indemnified by the corporation.

     

    Under Article VII of our Amended and Restated Bylaws, we are required to indemnify and hold harmless, to the fullest extent permitted by Nevada law, each director or officer who was or is a party to, or is threatened to be made a party to, or is otherwise involved in, any threatened, pending, or completed action, suit or proceeding, by reason of the fact that he or she is or was a director or officer or member, manager, or managing member of a predecessor limited liability company or affiliate of such limited liability company, or is or was serving in any capacity at our request as a director, officer, employee, agent, partner, member, manager, or fiduciary of, or in any other capacity for, another corporation or any partnership, joint venture, limited liability company, trust, or other enterprise or affiliate. Indemnification may not be made to or on behalf of an indemnitee if a final adjudication establishes that his or her acts or omissions involved intentional misconduct, fraud, or a knowing violation of law and was material to the cause of action. Furthermore, we are required to advance expenses to an indemnitee in advance of a final disposition of the proceeding.

     

    The indemnification provided by our Amended and Restated Articles of Incorporation and Amended and Restated Bylaws is not exclusive of any rights to which those indemnified may be entitled under any agreement, vote of stockholders or disinterested directors or otherwise, both as to action in his official capacity and as to action in another capacity while holding such office, and shall continue as to a person who has ceased to be a director, officer, employee, or agent and shall inure to the benefit of the heirs, executors, and administrators of such a person.

     

    Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of our company pursuant to the Nevada law, our Amended and Restated Articles of Incorporation, our Amended and Restated Bylaws or any of our indemnification agreements with our directors and officers, we have been informed that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

     

    We maintain a Directors’ and Officers’ Liability Insurance Policy designed to reimburse us for any covered payments made by us pursuant to the foregoing indemnification.

     

     

     

     

     4 

     

     

    Item 7. Exemption from Registration Claimed.

     

    Not applicable.

     

    Item 8. Exhibits.

     

    Exhibit Number

     

    Description

    5.1*   Opinion of Greenberg Traurig, LLP
         
    10.1   Paysign, Inc. 2023 Equity Incentive Plan (1)
         
    23.1*   Consent of Moss Adams LLP, independent registered public accounting firm
         
    23.2*   Consent of Greenberg Traurig, LLP (included in opinion filed as Exhibit 5.1)
         
    24.1*   Power of Attorney (included on signature page hereof)
         
    107*   Filing Fee Table

     

    *Filed herewith.
    (1)Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on May 9, 2023 (File Number 001-38623).

     

     

     

     

     

     

     

     

     

     

     

     

     5 

     

     

    Item 9. Undertakings.

     

    A.The undersigned registrant hereby undertakes:

     

    (1)                To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

     

    (i)                  To include any prospectus required by Section 10(a)(3) of the Securities Act;

     

    (ii)                To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

     

    (iii)              To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement;

     

    provided, however, that paragraphs (A)(1)(i) and (A)(1)(ii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.

     

    (2)                That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

    (3)                To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

     

    B.            The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefits plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

    C.            Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that, in the opinion of the Commission, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

     

     

     

     

     

     6 

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Henderson, State of Nevada, on


    August 7, 2024.

     

      PAYSIGN, INC.
         
      By: /s/ Mark R. Newcomer
        Mark R. Newcomer
        Chief Executive Officer

     

    POWER OF ATTORNEY

     

    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Mark R. Newcomer and Robert Strobo, and each of them, as his or her true and lawful attorney-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place, and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

     

    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

     

    Signature

    Title

    Date

         

    /s/ Mark R. Newcomer

    Chief Executive Officer, President, Director and Chairman
    (Principal Executive Officer)
    August 7, 2024
    Mark R. Newcomer
         

    /s/ Jeff Baker

    Chief Financial Officer and Treasurer
    (Principal Financial Officer and Principal Accounting Officer)
    August 7, 2024
    Jeff Baker
         

    /s/ Matthew Lanford

    Chief Payments Officer and Director August 7, 2024
    Matthew Lanford
         

    /s/ Joan M. Herman

    Executive Vice President and Director August 7, 2024
    Joan M. Herman
         

    /s/ Dan R. Henry

    Director August 7, 2024
    Dan R. Henry
         

    /s/ Bruce Mina

    Director August 7, 2024
    Bruce Mina
         

    /s/ Jeffrey B. Newman

    Director August 7, 2024
    Jeffrey B. Newman
         

    /s/ Dennis Triplett

    Director August 7, 2024
    Dennis Triplett

     

     

     

     7 

    Get the next $PAYS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PAYS

    DatePrice TargetRatingAnalyst
    12/20/2024$6.00Buy
    Lake Street
    3/30/2022$4.00Mkt Perform
    Barrington Research
    3/24/2022Buy → Neutral
    Ladenburg Thalmann
    8/20/2021$3.50Neutral → Buy
    DA Davidson
    8/19/2021Neutral → Buy
    DA Davidson
    8/12/2021$3.50 → $3.75Neutral → Buy
    Ladenburg Thalmann
    More analyst ratings

    $PAYS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference

    Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced it will be presenting at the Oppenheimer 11th Annual Emerging Growth Conference to be held February 3-4, 2026, through a virtual format. The focus of the virtual conference is to feature one-on-one and small group meetings with emerging companies in technology, industrial growth and consumer sectors. Paysign's Chief Financial Officer, Jeff Baker, will host one-on-one meetings on Tuesday, February 3. Investors interested in registering may contact their Oppe

    1/21/26 4:30:00 PM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability Solutions

    Dynamic Business Rules Demonstrates the Company's Advanced Capabilities in Mitigating Copay Maximizers, Exiting 2025 With 131 Active Programs Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions and integrated payment processing for the life sciences industries, today announced its annual performance analysis of pharmaceutical copay programs. The company added 55 programs during 2025, exiting the year with 131 programs – many incorporating Paysign's Dynamic Business Rules feature, which saved pharmaceutical clients more than $325 million by mitigating the harmful financial impact of copay maximizers on patients and program sponso

    1/7/26 8:05:00 AM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor Conference

    Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced they will be presenting at the 17th Annual Southwest IDEAS Investor Conference to be held Wednesday and Thursday, November 19 and 20, 2025, in Dallas, Texas. The conference is an annual invitation-only event, featuring quality public companies to interact with top institutional investors. The format has been designed to give attendees direct access to senior management via one-on-one and group meeting formats. Paysign's Chief Financial Officer, Jeff Baker,

    11/13/25 4:30:00 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Strobo Robert sold $109,400 worth of shares (20,000 units at $5.47), decreasing direct ownership by 6% to 327,290 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    12/12/25 6:08:20 PM ET
    $PAYS
    EDP Services
    Technology

    Chief Legal Officer Strobo Robert was granted 100,000 shares, increasing direct ownership by 40% to 347,290 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    9/26/25 8:06:46 PM ET
    $PAYS
    EDP Services
    Technology

    CEO Newcomer Mark was granted 200,000 shares, increasing direct ownership by 2% to 8,950,728 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    9/26/25 8:06:31 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    SEC Filings

    View All

    SEC Form 10-Q filed by Paysign Inc.

    10-Q - Paysign, Inc. (0001496443) (Filer)

    11/13/25 7:17:54 AM ET
    $PAYS
    EDP Services
    Technology

    Paysign Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Paysign, Inc. (0001496443) (Filer)

    11/12/25 5:09:55 PM ET
    $PAYS
    EDP Services
    Technology

    Paysign Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Paysign, Inc. (0001496443) (Filer)

    9/15/25 9:01:05 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on PaySign with a new price target

    Lake Street initiated coverage of PaySign with a rating of Buy and set a new price target of $6.00

    12/20/24 8:45:02 AM ET
    $PAYS
    EDP Services
    Technology

    Barrington Research initiated coverage on PaySign with a new price target

    Barrington Research initiated coverage of PaySign with a rating of Mkt Perform and set a new price target of $4.00

    3/30/22 8:15:53 AM ET
    $PAYS
    EDP Services
    Technology

    PaySign downgraded by Ladenburg Thalmann

    Ladenburg Thalmann downgraded PaySign from Buy to Neutral

    3/24/22 7:30:30 AM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Henry Daniel R bought $50,000 worth of shares (10,084 units at $4.96), increasing direct ownership by 8% to 129,884 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    6/16/25 9:00:04 PM ET
    $PAYS
    EDP Services
    Technology

    Director Henry Daniel R bought $67,716 worth of shares (19,800 units at $3.42), increasing direct ownership by 25% to 99,800 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    5/28/25 8:07:31 PM ET
    $PAYS
    EDP Services
    Technology

    Mina Bruce A bought $5,801 worth of shares (1,206 units at $4.81), increasing direct ownership by 0.56% to 218,500 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    5/15/24 6:19:59 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Paysign Inc.

    SC 13G/A - Paysign, Inc. (0001496443) (Subject)

    11/14/24 7:00:30 AM ET
    $PAYS
    EDP Services
    Technology

    SEC Form SC 13G/A filed by Paysign Inc. (Amendment)

    SC 13G/A - Paysign, Inc. (0001496443) (Subject)

    2/12/24 12:36:58 PM ET
    $PAYS
    EDP Services
    Technology

    SEC Form SC 13G/A filed by Paysign Inc. (Amendment)

    SC 13G/A - Paysign, Inc. (0001496443) (Subject)

    1/24/24 4:05:27 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Financials

    Live finance-specific insights

    View All

    Paysign, Inc. Reports Third Quarter 2025 Financial Results

    Delivered strong performance with record revenue and improved profitability Third quarter 2025 total revenues of $21.60 million, up 41.6% from third quarter 2024 Third quarter 2025 net income of $2.22 million, up 54.2% from $1.44 million a year ago, while diluted earnings per share was $0.04 versus $0.03 for third quarter 2024 Third quarter 2025 Adjusted EBITDA of $5.04 million (23.3% of revenues), up 78.1% from $2.83 million (18.5% of revenues) a year ago, while diluted Adjusted EBITDA per share was $0.08 versus $0.05 for third quarter 20241 Year-over-year plasma revenue increased 12.4% to $12.86 million; exited the quarter with 595 plasma centers, an increase of 117 plasma ce

    11/12/25 4:05:00 PM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. Reports Second Quarter 2025 Financial Results

    Second quarter 2025 total revenues of $19.08 million, up 33.1% from second quarter 2024 Second quarter 2025 net income of $1.39 million, up 99.1% from $697 thousand a year ago, while diluted earnings per share was $0.02, versus $0.01 for second quarter 2024 Second quarter 2025 Adjusted EBITDA of $4.51 million, up 101.8% from $2.24 million a year ago, while diluted Adjusted EBITDA per share was $0.08 versus $0.04 for second quarter 20241 Added 123 net plasma centers during second quarter 2025, all which went live June 16. We exited the quarter with 607 centers; average monthly revenue per plasma center decreased to $7,098 compared to $7,916 for the same period last year; year-over-

    8/5/25 4:05:00 PM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. Reports First Quarter 2025 Financial Results

    First quarter 2025 total revenues of $18.60 million, up 41.0% from first quarter 2024 First quarter 2025 net income of $2.59 million, or diluted earnings per share of $0.05, versus net income of $309 thousand, or diluted earnings per share of $0.01, for first quarter 2024 First quarter 2025 Adjusted EBITDA of $4.96 million, up 193.3% from $1.69 million a year ago, while diluted Adjusted EBITDA per share was $0.09 versus $0.03 for first quarter 20241 Total plasma center count increased by four net centers during first quarter 2025, exiting the quarter with 484 centers; revenue per plasma center decreased to $6,517 compared to $7,414 for the same period last year; year-over-year plasma

    5/8/25 4:05:00 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Leadership Updates

    Live Leadership Updates

    View All

    Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions

    Garcia Tapped to Lead Strategy for Company's Life Science Solutions Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management software platforms and integrated payment processing for the life sciences industries, today announced that it has appointed Jose Garcia as Executive Vice President, Life Science Solutions. In his new role at Paysign, Mr. Garcia will implement and execute the market strategy for the company's comprehensive suite of engagement and management solutions targeting the life sciences industries. With more than two decades of executive experience in life sciences services, Mr. Garcia is a

    9/22/25 8:05:00 AM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. Announces Acquisition of Gamma Innovation's Assets, Appoints Michael Ngo as Chief Innovation Officer

    Paysign Strengthens Leadership in Technology for Plasma and Pharmaceutical Industries  Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced that it has acquired the assets of Gamma Innovation LLC (Gamma), significantly enhancing Paysign's capabilities in plasma donor and pharmaceutical patient engagement technologies. As part of this strategic acquisition, Paysign has appointed Michael Ngo, former Managing Member of Gamma, as its Chief Innovation Officer. "This acquisition represents an exciting milestone for Paysign as we accelerate our growth strategy and expand our

    3/25/25 8:05:00 AM ET
    $PAYS
    EDP Services
    Technology